Comment on Joseph Farrell, David J. Balan, Keith Brand, Brett W. Wendling (2011), 'Economics at the FTC: Hospital Mergers, Authorized Generic Drugs, and Consumer Credit Markets'
15 Pages Posted: 4 May 2012 Last revised: 19 Sep 2014
Date Written: June 19, 2012
Abstract
In a review of “Economics at the FTC,” Farrell et al. (2011) discuss empirical methods FTC economists use to assess the potential price effects of prospective hospital mergers. The primary method is a framework based on proxies for the bargaining power of hospitals that are calculated from the estimated parameters of a model of patient hospital choice. The effect of these proxies for bargaining power on the reimbursement rates obtained by hospitals in negotiations with payors is then estimated using a reduced form specification. We discuss the limitations of this framework, and provide a few examples in which it may fail to predict the price effects of hospital mergers reliably, especially in the presence of restricted insurance networks.
Suggested Citation: Suggested Citation
Do you have negative results from your research you’d like to share?
Recommended Papers
-
Competition in Health Care Markets
By Martin Gaynor and Robert J. Town
-
Antitrust and Competition in Health Care Markets
By Martin Gaynor and William B. Vogt
-
Antitrust and Competition in Health Care Markets
By Martin Gaynor and William B. Vogt
-
Change, Consolidation, and Competition in Health Care Markets
By Martin Gaynor and Deborah Haas-wilson
-
Change, Consolidation, and Competition in Health Care Markets
By Martin Gaynor and Deborah Haas-wilson
-
Are Invisible Hands Good Hands? Moral Hazard, Competition, and the 2nd Best in Health Care Markets
By Martin Gaynor, Deborah Haas-wilson, ...
-
By Martin Gaynor, Deborah Haas-wilson, ...
-
By Martin Gaynor and William B. Vogt
-
By Martin Gaynor and William B. Vogt